PM360

JUNE 26, 2023

Patients struggle to get the necessary treatments, in some cases resulting in increased hospitalization and death. The end-to-end supply chain comprises material procurement, manufacturing, transportation, warehousing, and distribution. drug manufacturers to continue producing generic drugs. Over 300 drugs in the U.S.

Manufacturing 97

Manufacturing Pharmaceutical manufacturing Pharma Management 97

Impetus Digital

AUGUST 2, 2024

The pharmaceutical industry has numerous use cases for AI. From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. It’s remarkable to see the progress made in the technology compared to only a few months ago and there are no signs of the progress slowing down.

Pharma 93

Pharma Manufacturing Medicine Marketing 93

pharmaphorum

AUGUST 4, 2022

For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches. Lynne Byers, global managing director, Pharmaceuticals and Dietary Supplements Consulting, NSF.

Recruitment 98

Recruitment Training Pharma Pharmaceutical manufacturing 98

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5

Prescription 105

Prescription Medical Patients Side effects 105

European Pharmaceutical Review

APRIL 18, 2024

Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE). About the author Andreas Häner is an environmental risk assessor at Roche in Group Safety, Security, Health & Environmental protection (SHE).

Pharmaceutical 97

Pharmaceutical Manufacturing Management Doctors 97

Pharmaceutical Technology

SEPTEMBER 13, 2022

An international team of scientific, regulatory, and safety and compliance (GxP) specialists, PharmaLex is based in Germany. The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Marketing 52

Pharmaceutical Technology

SEPTEMBER 6, 2022

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Pharmaceutical 59

Pharmaceutical Leads Pharma Transportation 59

pharmaphorum

NOVEMBER 25, 2022

Going beyond the standards of care; improving drug safety and efficacy. What the Chiesi Group is doing is making people safe and people’s safety comes first in any system, he said. But to make people safe requires a lot of research. The President of the Emilia-Romagna Region, Stefano Bonaccini, took turn to speak next.

Pharmaceutical 98

Pharmaceutical Manufacturing Medicine Competition 98

Pharmaceutical Technology

AUGUST 3, 2022

The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development. If clinical trials prove successful, that same process should then be scaled to commercial manufacturing. One size (never) fits all.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Safety Pharmaceutical Manufacturing 52

PM360

JANUARY 24, 2025

AI supports marketers in key areas such as personalized campaigns (with tailored messages to healthcare professionals (HCPs) and patients), predictive analytics, and social sentiment analysis. SLRs aim to answer specific questions related to drug safety, efficacy, and comparative effectiveness, often contributing to GVDs.

Marketing 64

Marketing Pharmaceutical Pharma Sales pitches 64

European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. Conclusion.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Medico Reach

FEBRUARY 8, 2023

The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. from 2023 to 2030.

Pharma 52

Pharma Medicine Marketing Prospecting 52

World of DTC Marketing

AUGUST 12, 2022

In the past 12 months, PhRMA and closely allied groups spent at least $57 million — $19 million of it since July — on TV , cable , radio , and social media ads opposing price negotiations, according to monitoring by the advocacy group Patients for Affordable Drugs. First, let’s clarify how the bill saves taxpayers billions.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

pharmaphorum

OCTOBER 26, 2022

And just as a family business thrives on its connection to the community, Chiesi is committed to connecting to the global patient community. We try to have a very long-term orientation because we believe that aligns our objectives very well with the objectives of society and the patients we serve, and it makes us a stable business.”.

Patients 96

Patients Pharma Consulting Transportation 96

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

PM360

DECEMBER 20, 2023

In 2021, a consensus was reached that classified rare diseases as those with an incidence of less than 1 in 10,000 newborns, or a prevalence of less than 1 in 10,000 adults, or a patient population of less than 140,000 in total. The GBA gives patients access to innovative drugs (e.g.,

Marketing 105

Marketing Insurance Medical Manufacturing 105

PM360

APRIL 25, 2023

The entirety of healthcare stakeholders is watching the biosimilars market closely because LOE events, particularly the Humira LOE, is likely to impact payers, providers, patients, and pharmaceutical manufacturers—both brand and biosimilar—and potentially society as a whole given the current controversy over rising drug prices.

Marketing 97

Marketing Competition Government Manufacturing 97

European Pharmaceutical Review

JULY 8, 2024

To say that 25°C is the only valid temperature is erroneous, but in view of the data generated in our context, it remains the optimum temperature for the detection of contamination in our production environment, thus guaranteeing drug quality and, ultimately, patient safety.

Food and Drug Administration 95

Food and Drug Administration Pharmaceutical Pharmaceutical manufacturing Pharma 95

Pharmaceutical Technology

MAY 11, 2008

Pharmaceutical companies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. The pilot scheme for this has been observed by the FDA and EU Commission.

Electronics 40

Electronics Transportation Pharmaceutical manufacturing Pharmaceutical 40

European Pharmaceutical Review

JULY 5, 2024

This follows publication of its Manifesto , which detailed recommendations such as increasing patient access to new treatments through clinical trials and enhancing the pharmaceutical manufacturing in the UK.

Pharma 98

Pharma Government Safety Medicine 98

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Impending change affords an opportunity for innovation.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

OCTOBER 3, 2024

Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.

Manufacturing 52

Manufacturing Pharmaceutical manufacturing Pharmaceutical Education 52